StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
21
Publishing Date
2024 - 04 - 09
24
2024 - 04 - 08
24
2024 - 03 - 05
29
2023 - 12 - 11
20
2023 - 11 - 13
22
2023 - 11 - 06
23
2023 - 11 - 03
29
2023 - 11 - 02
57
2023 - 09 - 27
26
2023 - 06 - 26
19
2023 - 06 - 05
27
2023 - 05 - 31
22
2023 - 05 - 30
21
2023 - 05 - 25
40
2023 - 05 - 24
21
2023 - 05 - 17
22
2023 - 05 - 11
21
2023 - 05 - 10
23
2023 - 05 - 09
19
2023 - 05 - 04
22
2023 - 05 - 02
22
2023 - 04 - 26
38
2023 - 04 - 19
23
2023 - 04 - 18
31
2023 - 04 - 17
32
2023 - 04 - 14
24
2023 - 04 - 11
20
2023 - 03 - 15
28
2023 - 03 - 14
49
2022 - 12 - 12
20
2022 - 11 - 10
29
2022 - 11 - 03
54
2022 - 10 - 05
27
2022 - 06 - 06
26
2022 - 06 - 01
18
2022 - 05 - 26
23
2022 - 05 - 02
24
2022 - 04 - 28
23
2022 - 04 - 08
49
2022 - 04 - 06
18
2022 - 03 - 08
50
2021 - 12 - 13
45
2021 - 11 - 12
31
2021 - 11 - 09
18
2021 - 11 - 04
40
2021 - 10 - 01
31
2021 - 06 - 10
18
2021 - 06 - 07
20
2021 - 06 - 04
25
2021 - 06 - 03
23
2021 - 05 - 20
21
2021 - 05 - 19
19
2021 - 05 - 13
19
2021 - 05 - 03
18
2021 - 04 - 29
26
2021 - 04 - 28
27
2021 - 04 - 27
26
2021 - 04 - 12
23
2021 - 04 - 10
21
2021 - 03 - 10
18
Sector
Commercial services
1
Health technology
19
Tags
Antibody
1
Biomarkers
1
Cancer
11
Cel
1
Drug
1
Growth
1
Kidney
1
Lung cancer
1
N/a
21
Ongoing
1
Phase 1
2
Phase 2
2
Phase 3
2
Potential
3
Pre-clinical
13
Preclinical
13
Presentation
4
Research
11
Results
1
Solid tumors
1
Therapy
1
Treatment
1
Trial
2
Entities
Advaxis, inc.
1
Alnylam pharmaceuticals, inc.
1
Black diamond therapeutics, inc.
1
Blueprint medicines corporation
1
C4 therapeutics, inc.
1
Essa pharma inc.
1
Genocea biosciences, inc.
1
Gilead sciences, inc.
1
Harpoon therapeutics, inc.
1
Iteos therapeutics, inc.
1
Jounce therapeutics, inc.
1
Kronos bio, inc.
1
Kymera therapeutics, inc.
1
Macrogenics, inc.
1
Mersana therapeutics, inc.
1
Nextcure, inc.
1
Nucana plc
1
Oncocyte corporation
1
Pmv pharmaceuticals, inc.
1
Synlogic, inc.
1
Tcr2 therapeutics inc.
1
Vincera pharma inc
1
Symbols
ADXS
1
ALNY
1
BDTX
1
BPMC
1
CCCC
1
EPIX
1
GILD
1
GNCA
1
HARP
1
ITOS
1
JNCE
1
KRON
1
KYMR
1
MGNX
1
MRSN
1
NCNA
1
NXTC
1
OCX
1
PMVP
1
SYBX
1
TCRR
1
VINC
1
Exchanges
Amex
1
Nasdaq
20
Crawled Date
2021 - 04 - 11
2
2021 - 04 - 10
19
Crawled Time
00:20
2
16:20
15
20:20
4
Source
www.alnylam.com
1
www.globenewswire.com
17
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
meeting
publishing date :
2021 - 04 - 10
save search
Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021
Published:
2021-04-10
(Crawled : 00:20)
- globenewswire.com
KYMR
|
$33.965
-3.29%
-3.4%
630K
|
Health Technology
|
Email alert
Add to watchlist
preclinical
pre-clinical
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
Published:
2021-04-10
(Crawled : 00:20)
- globenewswire.com
BDTX
|
$5.26
-0.76%
-0.76%
390K
|
Health Technology
|
Email alert
Add to watchlist
presentation
cancer
research
preclinical
pre-clinical
New Analyses of OXLUMO® (lumasiran) ILLUMINATE-A Results at the National Kidney Foundation Virtual Spring Clinical Meetings
Published:
2021-04-10
(Crawled : 20:20)
- alnylam.com
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
Email alert
Add to watchlist
results
kidney
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
Published:
2021-04-10
(Crawled : 20:20)
- globenewswire.com
OCX
|
News
J
|
$2.495
-2.54%
-2.61%
50K
|
Health Technology
|
Email alert
Add to watchlist
potential
cancer
research
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
Published:
2021-04-10
(Crawled : 20:20)
- globenewswire.com
PMVP
|
$1.61
-0.62%
-0.62%
480K
|
Commercial Services
|
Email alert
Add to watchlist
cancer
research
preclinical
pre-clinical
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
Published:
2021-04-10
(Crawled : 20:20)
- globenewswire.com
CCCC
|
$6.74
-2.46%
-2.52%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
treatment
preclinical
pre-clinical
Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- prnewswire.com
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
Email alert
Add to watchlist
therapy
research
preclinical
pre-clinical
ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting
Published:
2021-04-10
(Crawled : 16:20)
- prnewswire.com
EPIX
|
$6.57
-2.23%
-2.28%
100K
|
Health Technology
|
Email alert
Add to watchlist
potential
cancer
research
preclinical
pre-clinical
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
Published:
2021-04-10
(Crawled : 16:20)
- prnewswire.com
SYBX
|
$1.815
-0.82%
-0.83%
54K
|
Health Technology
|
Email alert
Add to watchlist
phase 1
cancer
research
trial
phase 3
phase 2
Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
KRON
|
$0.99
-3.88%
-4.04%
120K
|
Health Technology
|
Email alert
Add to watchlist
cancer
growth
preclinical
pre-clinical
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
MGNX
|
$15.62
-2.8%
-2.88%
1M
|
Health Technology
|
Email alert
Add to watchlist
presentation
iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
ITOS
|
$10.58
2.42%
2.36%
940K
|
Health Technology
|
Email alert
Add to watchlist
antibody
Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
HARP
|
$23.01
0.07%
6.6M
|
Health Technology
|
Email alert
Add to watchlist
presentation
NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
NXTC
|
$1.67
6.37%
5.99%
62K
|
Health Technology
|
Email alert
Add to watchlist
cancer
research
preclinical
pre-clinical
Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
GNCA
|
$0.051
|
Health Technology
|
Email alert
Add to watchlist
preclinical
pre-clinical
NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
NCNA
|
$3.81
0.53%
0.52%
33K
|
Health Technology
|
Email alert
Add to watchlist
presentation
cancer
research
Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research (AACR) 2021 Annual Meeting
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
ADXS
|
$0.57
12.48%
9.5K
|
Health Technology
|
Email alert
Add to watchlist
lung cancer
ongoing
phase 1
cancer
research
trial
phase 3
phase 2
biomarkers
Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
JNCE
|
$1.88
-2.59%
-1.85%
0
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
cancer
research
preclinical
pre-clinical
Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
VINC
|
$0.8475
-5.83%
-6.19%
350K
|
|
Email alert
Add to watchlist
cancer
drug
research
preclinical
pre-clinical
TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
Published:
2021-04-10
(Crawled : 16:20)
- globenewswire.com
TCRR
4
|
$1.48
3.38%
3.9M
|
Health Technology
|
Email alert
Add to watchlist
solid tumors
preclinical
cel
pre-clinical
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.